Hepcidin-induced iron deficiency is related to transient anemia and hypoferremia in Kawasaki disease patients

30Citations
Citations of this article
43Readers
Mendeley users who have this article in their library.

Abstract

Kawasaki disease (KD) is a type of systemic vasculitis that primarily affects children under the age of five years old. For sufferers of KD, intravenous immunoglobulin (IVIG) has been found to successfully diminish the occurrence of coronary artery lesions. Anemia is commonly found in KD patients, and we have shown that in appropriately elevated hepcidin levels are related to decreased hemoglobin levels in these patients. In this study, we investigated the time period of anemia and iron metabolism during different stages of KD. A total of 100 patients with KD and 20 control subjects were enrolled in this study for red blood cell and hemoglobin analysis. Furthermore, plasma, urine hepcidin, and plasma IL-6 levels were evaluated using enzyme-linked immunosorbent assay in 20 KD patients and controls. Changes in hemoglobin, plasma iron levels, and total iron binding capacity (TIBC) were also measured in patients with KD. Hemoglobin, iron levels, and TIBC were lower (p < 0.001, p = 0.009, and p < 0.001, respectively) while plasma IL-6 and hepcidin levels (both p < 0.001) were higher in patients with KD than in the controls prior to IVIG administration. Moreover, plasma hepcidin levels were positively and significantly correlated with urine hepcidin levels (p < 0.001) prior to IVIG administration. After IVIG treatment, plasma hepcidin and hemoglobin levels significantly decreased (both p < 0.001). Of particular note was a subsequent gradual increase in hemoglobin levels during the three weeks after IVIG treatment; nevertheless, the hemoglobin levels stayed lower in KD patients than in the controls (p = 0.045). These findings provide a longitudinal study of hemoglobin changes and among the first evidence that hepcidin induces transient anemia and hypoferremia during KD’s acute inflammatory phase.

Author supplied keywords

References Powered by Scopus

Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization

4070Citations
N/AReaders
Get full text

The Treatment of Kawasaki Syndrome with Intravenous Gamma Globulin

1249Citations
N/AReaders
Get full text

Diagnosis, treatment, and long-term management of Kawasaki disease: A statement for health professionals from the committee on rheumatic fever, endocarditis, and Kawasaki disease, council on cardiovascular disease in the young, American Heart Association

1177Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Identifying genetic hypomethylation and upregulation of tolllike receptors in Kawasaki disease

42Citations
N/AReaders
Get full text

HAMP promoter hypomethylation and increased hepcidin levels as biomarkers for Kawasaki disease

29Citations
N/AReaders
Get full text

Anemia in Kawasaki disease: Hepcidin as a potential biomarker

26Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Huang, Y. H., Kuo, H. C., Huang, F. C., Yu, H. R., Hsieh, K. S., Yang, Y. L., … Kuo, H. C. (2016). Hepcidin-induced iron deficiency is related to transient anemia and hypoferremia in Kawasaki disease patients. International Journal of Molecular Sciences, 17(5). https://doi.org/10.3390/ijms17050715

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 8

44%

Researcher 7

39%

Lecturer / Post doc 2

11%

Professor / Associate Prof. 1

6%

Readers' Discipline

Tooltip

Medicine and Dentistry 10

56%

Pharmacology, Toxicology and Pharmaceut... 5

28%

Biochemistry, Genetics and Molecular Bi... 2

11%

Nursing and Health Professions 1

6%

Save time finding and organizing research with Mendeley

Sign up for free